Journal article

Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial

NC Tebbutt, MM Parry, D Zannino, AH Strickland, GA Van Hazel, N Pavlakis, V Ganju, D Mellor, A Dobrovic, VJ Gebski

British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2013